Overview of motor neuron disease: Classification and nomenclature

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Amyotrophic lateral sclerosis (ALS), although a disease that has been well recognized for nearly 150 years, still causes problems of diagnosis and management, as there is no definitive diagnostic test, and the disease is pleomorphic. Research criteria were developed for the categorization of definite, probable, and possible ALS at the El Escorial Workshop (published in 1994). The principal features are upper and lower motor neuron signs at several levels of the neuraxis, without involvement of other neurological systems. Separation of ALS or motor neuron disease (MND) from the spinal muscular atrophies or hereditary spastic paraplegia can be difficult. The relatively rapid progression to death in an average of 5 years is one of the hallmarks of ALS. However, some cases are relatively more benign. The recent finding that mutations of the SOD1 gene underlie about 20% of familial cases of ALS has allowed the recognition that all phenotypes can occur in different members of the same family with the same mutation, clarifying earlier suggestions that different phenotypes represent different diseases. Until the cause and cure of ALS are found, neurologists and rehabilitation specialists must continue to provide essential support for patients with this devastating disease.

Original languageEnglish
Pages (from-to)323-326
Number of pages4
JournalClinical Neuroscience
Volume3
Issue number6
StatePublished - Dec 1 1995

Fingerprint

Motor Neuron Disease
Amyotrophic Lateral Sclerosis
Terminology
Hereditary Spastic Paraplegia
Phenotype
Spinal Muscular Atrophy
Mutation
Motor Neurons
Routine Diagnostic Tests
Rehabilitation
Education
Research
Genes

Keywords

  • diagnostic criteria
  • familial ALS
  • phenotypic subtypes
  • psychological aspects
  • upper and lower motor neuron

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Overview of motor neuron disease : Classification and nomenclature. / Bradley, Walter G.

In: Clinical Neuroscience, Vol. 3, No. 6, 01.12.1995, p. 323-326.

Research output: Contribution to journalArticle

@article{18e75a24a7a3431a868b1f8dd7ce41a2,
title = "Overview of motor neuron disease: Classification and nomenclature",
abstract = "Amyotrophic lateral sclerosis (ALS), although a disease that has been well recognized for nearly 150 years, still causes problems of diagnosis and management, as there is no definitive diagnostic test, and the disease is pleomorphic. Research criteria were developed for the categorization of definite, probable, and possible ALS at the El Escorial Workshop (published in 1994). The principal features are upper and lower motor neuron signs at several levels of the neuraxis, without involvement of other neurological systems. Separation of ALS or motor neuron disease (MND) from the spinal muscular atrophies or hereditary spastic paraplegia can be difficult. The relatively rapid progression to death in an average of 5 years is one of the hallmarks of ALS. However, some cases are relatively more benign. The recent finding that mutations of the SOD1 gene underlie about 20{\%} of familial cases of ALS has allowed the recognition that all phenotypes can occur in different members of the same family with the same mutation, clarifying earlier suggestions that different phenotypes represent different diseases. Until the cause and cure of ALS are found, neurologists and rehabilitation specialists must continue to provide essential support for patients with this devastating disease.",
keywords = "diagnostic criteria, familial ALS, phenotypic subtypes, psychological aspects, upper and lower motor neuron",
author = "Bradley, {Walter G}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "3",
pages = "323--326",
journal = "Clinical Neuroscience",
issn = "1065-6766",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Overview of motor neuron disease

T2 - Classification and nomenclature

AU - Bradley, Walter G

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Amyotrophic lateral sclerosis (ALS), although a disease that has been well recognized for nearly 150 years, still causes problems of diagnosis and management, as there is no definitive diagnostic test, and the disease is pleomorphic. Research criteria were developed for the categorization of definite, probable, and possible ALS at the El Escorial Workshop (published in 1994). The principal features are upper and lower motor neuron signs at several levels of the neuraxis, without involvement of other neurological systems. Separation of ALS or motor neuron disease (MND) from the spinal muscular atrophies or hereditary spastic paraplegia can be difficult. The relatively rapid progression to death in an average of 5 years is one of the hallmarks of ALS. However, some cases are relatively more benign. The recent finding that mutations of the SOD1 gene underlie about 20% of familial cases of ALS has allowed the recognition that all phenotypes can occur in different members of the same family with the same mutation, clarifying earlier suggestions that different phenotypes represent different diseases. Until the cause and cure of ALS are found, neurologists and rehabilitation specialists must continue to provide essential support for patients with this devastating disease.

AB - Amyotrophic lateral sclerosis (ALS), although a disease that has been well recognized for nearly 150 years, still causes problems of diagnosis and management, as there is no definitive diagnostic test, and the disease is pleomorphic. Research criteria were developed for the categorization of definite, probable, and possible ALS at the El Escorial Workshop (published in 1994). The principal features are upper and lower motor neuron signs at several levels of the neuraxis, without involvement of other neurological systems. Separation of ALS or motor neuron disease (MND) from the spinal muscular atrophies or hereditary spastic paraplegia can be difficult. The relatively rapid progression to death in an average of 5 years is one of the hallmarks of ALS. However, some cases are relatively more benign. The recent finding that mutations of the SOD1 gene underlie about 20% of familial cases of ALS has allowed the recognition that all phenotypes can occur in different members of the same family with the same mutation, clarifying earlier suggestions that different phenotypes represent different diseases. Until the cause and cure of ALS are found, neurologists and rehabilitation specialists must continue to provide essential support for patients with this devastating disease.

KW - diagnostic criteria

KW - familial ALS

KW - phenotypic subtypes

KW - psychological aspects

KW - upper and lower motor neuron

UR - http://www.scopus.com/inward/record.url?scp=0029435250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029435250&partnerID=8YFLogxK

M3 - Article

C2 - 9021252

AN - SCOPUS:0029435250

VL - 3

SP - 323

EP - 326

JO - Clinical Neuroscience

JF - Clinical Neuroscience

SN - 1065-6766

IS - 6

ER -